Qianhong Bio-pharma released its performance for the first half of the year, with a net profit attributable to the parent company of 258 million yuan, an increase of 41.17%

According to the Zhitong Finance APP, Qianhong Bio-pharma (002550.SZ) released its semi-annual report for 2025, reporting an operating income of 862 million yuan, a year-on-year increase of 0.72%. The net profit attributable to shareholders of the listed company was 258 million yuan, a year-on-year increase of 41.17%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 199 million yuan, a year-on-year increase of 10.71%. The basic earnings per share were 0.2065 yuan